Altria sees revenue decline in Q3, but its oral portfolio is on the rise

Altria posted a 4.7% revenue decline in the third quarter of the year, mainly driven by the continuing poor performance of its smokable segment but neutralised by the growth of its oral products in the US.

The Big Tobacco posted net revenues of $6.8bn in the period, while in the same period of 2020 it achieved $7.1bn. In the first nine months of the year, the company posted $19.7bn in revenues (+0.5%).

Read full article
I'm already a subscriber

Antonia Di Lorenzo

Assistant news editor/senior reporter
Antonia is a member of the editorial team and holds a masters degree in Law from the University of Naples Federico II, Italy. She moved in 2013 to London, where she completed a postgraduate course at the London School of Journalism. In the UK, she worked as a news reporter for a financial newswire and a magazine before moving to Barcelona in 2019.

Our Key Benefits

The global novel nicotine market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

TobaccoIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organisation